Drug Discovery App CS WP
-
Time To Intensify: Taking mAb Manufacturing To The Next Level
8/19/2025
Explore how process intensification can revolutionize monoclonal antibody manufacturing to boost productivity, cut costs, and enhance sustainability with scalable strategies and real-world results.
-
Cell Line Development For Bispecific Antibodies
8/18/2025
See how the recently described cell line development paradigm shift, enabled by the Leap-In transposon platform, can extend to the development of bispecific monoclonal antibody-producing cell substrates.
-
Zero to Final Fill: How HUGEL Implemented Its First Single-Use Lines
8/6/2025
As regulations tighten, biomanufacturers are adopting single-use tech to boost compliance, reduce labor, and streamline fill-finish operations from the ground up.
-
Optimizing CHO Cell Culture Using A Design Of Experiments Approach
8/6/2025
Learn how researchers optimized CHO cell culture to boost IgG1 titer to 5.8 g/L and improve viability, which cut development time from 14 days to 12 while enhancing productivity.
-
Pre-Clinical Risk Assessment Of PCSK9 Guide RNAs
8/5/2025
Learn how a comprehensive, variant-aware screening workflow for therapeutic gene editing can identify and nominate the most favorable guide RNAs for clinical development.
-
Balancing Protein A Resin Cost, Performance, And Productivity
7/31/2025
Optimizing input parameters like DBC, flow rate, and resin durability is key to boosting productivity in downstream bioprocessing. Discover how to tailor resin choices to meet your specific process requirements.
-
Rapid Production Of Assay Ready Cells For GPCR Drug Discovery
7/29/2025
Accelerate drug discovery by leveraging transiently transfected assay-ready cells. This method improves assay sensitivity and reduces variability for GPCRs.
-
A Novel Cell-Based Assay For Ubiquitin Drug Discovery
7/29/2025
Learn about a novel cell-based assay that can advance ubiquitin ligase drug discovery. This high-throughput method simplifies assay development, saving time and resources.
-
High-Throughput Screening Of Ion Channel Variants Using Automated Patch Clamp Recordings In Assay Ready Cells
7/29/2025
High-throughput screening of KCNQ2 ion channel variants provides insights into epilepsy and treatment responses. This validated method supports rapid characterization for precision medicine.
-
Risk Assessment Services Align With FDA Guidance For Gene-Edited Human Gene Therapy Products
7/29/2025
Navigate the FDA's gene therapy guidelines with advanced risk assessment strategies. Optimize gene editing and ensure regulatory alignment for safer, more effective therapies.